Mode
Text Size
Log in / Sign up
N/A N=128 Randomized Treatment

Cognitive Rehabilitation of Operations Iraqi Freedom and Enduring Freedom (OIF/OEF) Veterans With Cognitive Disorder

Cognition Disorders

Enrolled (actual)
128
Serious AEs
0.0%
Results posted
Jan 2015
Primary outcome: Primary: Multiple Sclerosis Neuropsychological Screening Questionnaire-Patient Version — 33.58; 36.35 units on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Cognitive Strategy Training (Behavioral); Placebo comparison group (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
US Department of Veterans Affairs
Primary completion
May 2013

Outcome Measures

OutcomeResultp-value
PRIMARY
Multiple Sclerosis Neuropsychological Screening Questionnaire-Patient Version
33.58; 36.35
SECONDARY
Prospective-Retrospective Memory Questionnaire (PRMQ; Crawford, Henry, Ward, &
49.56; 55.20
SECONDARY
The Neurobehavioral Symptom Inventory
40.89; 43.52
SECONDARY
Memory Compensation Questionnaire
123.08; 119.52
SECONDARY
Hopkins Verbal Memory Test-Revised
50.50; 44.75
SECONDARY
Wechsler Adult Intelligence Scale-3rd Edition, Digit Span Subtest
28.39; 28.58
SECONDARY
Delis-Kaplan Executive Function System, Trails Subtest
9.89; 10.38
SECONDARY
Delis-Kaplan Executive Function System, Verbal Fluency Subtest
11.31; 10.63
SECONDARY
PTSD Checklist-Military Version
53.22; 57.18
SECONDARY
Beck Depression Inventory, Second Edition
20.53; 23.75
SECONDARY
Severity of Dependence Scale
0.67; 0.73
SECONDARY
Satisfaction With Life Scale
17.44; 17.69

Summary

The number of OEF/OIF veterans seeking care and rehabilitation services within the VA Health Care System is increasing rapidly. The cognitive effects of MTBI are clinically significant and can adversely affect a veteran's ability to reintegrate into civilian life, return to duty, succeed in competitive employment, or function independently. The primary product of the proposed study would be an empirically validated, manualized, cognitive rehabilitation intervention for OIF/OIF veterans with cognitive disorders. The group treatment modality has the virtue of efficiency and a manualized treatment approach would allow wide-ranging application throughout the VHA system. As such, the proposed study is likely to have a significant effect on the quality and effectiveness of rehabilitative services being offered to our returning soldiers with combat-related MTBI and cognitive impairment.

Eligibility Criteria

Inclusion Criteria

  • OEF/OIF veterans enrolled at a participating VA who are able to provide informed consent; and
  • As part of standard VA clinical care, have screened positive for MTBI and complain of cognitive impairment.

Exclusion Criteria

  • Current substance use disorder with less than 30 days abstinence;
  • History of a primary psychotic disorder; and
  • Auditory or visual impairments that would prevent ability to participate in the cognitive rehabilitation group or benefit from compensatory strategies.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01040858). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search